Abstract:BACKGROUND: The plasma level of neuron specific enolase (NSE) can be used to diagnose and evaluate neuronal injury and predict early prognosis. OBJECTIVE: To observe the dynamic changes in plasma levels of NSE in patients with acute cerebral infarction, and to investigate its correlations with disease severity and prognosis. DESIGN, TIME AND SETTING: This non-randomized, concurrent case-control experiment was performed at the Department of Neurology, First Hospital Affiliated to Heilongjiang University of Traditional Chinese Medicine between May and July 2007. PARTICIPANTS: Eighteen patients with acute cerebral infarction, who received treatment at the Department of Neurology, First Hospital Affiliated to Heilongjiang University of Traditional Chinese Medicine between May and July 2007, were recruited into the patient group. An additional 10 healthy individuals, who received health examinations simultaneously, were included as controls. METHODS: Following admission (within 3 days) and at days 6, 12, and 30 subsequent to acute cerebral infarction attack, 3 mL venous blood was taken from each patient before the morning meal to determine the plasma level of NSE by enzyme-labeled immunosorbent assay. One-time blood extraction was performed in each healthy subject during the health examination for the same purpose as in patients. At 6 and 30 days following acute cerebral infarction attack, CT examination was performed for calculation of cerebral infarction volume according to the Tada formula. Following admission and at 30 days of disease invasion, all patients were scored by the National Institutes of Health Stroke Scale (NIHSS, 13 items). MAIN OUTCOME MEASURES: Comparison of NSE plasma level between acute cerebral infarction patients and healthy individuals; correlations of NSE plasma level in acute cerebral infarction patients with cerebral infarction volume, NIHSS score, and prognosis. RESULTS: Following admission and at days 6 and 12 of disease invasion, the plasma level of NSE was significantly higher in the patient group than in the control group (P < 0.05). Following admission and at day 30 of disease invasion, the NIHSS scores of the patient group were 17.706 and 11.222, respectively. Following admission and at day 6 of disease invasion, the plasma level of NSE was positively correlated with cerebral infarction volume (r = 0.503, 0.435, P < 0.05), but it was negatively correlated with NIHSS score (r = -0.571, 0.368, P < 0.05). The plasma level of NSE was mostly correlated with cerebral infarction volume, followed by NIHSS score, and lastly prognosis, with regression coefficients of 0.386, 0.343, and 0.340, respectively. CONCLUSION: The plasma level of NSE is higher in patients with acute cerebral infarction than in the healthy population. It can reflect infarct severity and predict early prognosis of acute cerebral infarction.

Change of serum Nogo-A protein in patients with acute closed brain injury

Early Changes of Endothelin, Nitric Oxide and Arginine-Vasopressin in Patients with Acute Cerebral Injury.

Neuroglobin and Nogo-a as biomarkers for the severity and prognosis of traumatic brain injury.

The Significance of Plasma Vascular Endothglial Growth Factor Change Closed Head Injury

Relationship between cerebrospinal fluidα-Synuclein and prognosis of patients with traumatic brain injury

Relationship study between serum brain red protein content and the de-gree of nerve injury in patients with brain injury

Dynamic Changes of Serum Glial Fibrillary Acidic Protein Content in Patients with Brain Injury and Their Cllnical Significance

Dynamic change of peripheral blood glial fibrillary acidic protein (GFAP) and neurospecifie enolase (NSE) in patients with craniocerebral injury

Serum netrin-1 as a potential biomarker for functional outcome of traumatic brain injury

The Change and Clinical Significance of Serum Aquaporin-4 and Pnf-H in Patients with Moderate and Severe Traumatic Brain Injury

Serum Neuron Specific Enolase and Matrix Metalloproteinases in Patients with Severe Traumatic Brain Injury and the Clinical Significance

Clinical Significance of Determination of Changes of Immuno-Function Parameters in Patients with Acute Severe Brain Injury on Different Froms of Nutritional Support

Research of Serum Neuron-specific Enolase to Evaluate the Prognosis of Severe Head Injury

Lactic Acid, Neuron-Specific Enolase, and Blood-Brain Barrier Index after a Severe Traumatic Brain Injury: a Prospective Study

Changes of NLRP3 in serum and cerebrospinal fluid of patients after moderate to severe traumatic brain injury and their predictive values for prognosis

Evaluation of severe brain injury prognosis by neuron-specific enolase, myelin basic protein

Changes in the levels of serum glial fibrillary acidic protein and the correlation with outcomes in severe traumatic brain injury patients

S-100B and Neuron Specific Enolase in Outcome Prediction of Severe Head Injury

Plasma level of neuron specific enolase in patients with acute cerebral infarction:A case-control study

Expression of heat shock protein 70 and Annexin A1 in serum of patients with acutely severe traumatic brain injury

The Dynamic Change of Neuron Specific Enolase Following Acute Brain Injury in Rats